EN
抗体药类似物
Research Grade Parsatuzumab
All
  • CatalogTD-HV171016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsRG7414,RO5490248,CAS:1312797-14-0
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Parsatuzumab


Catalog No. TD-HV171016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target NOTCH4-like protein, Zneu1, Multiple EGF-like domains protein 7, Epidermal growth factor-like protein 7, MEGF7, EGFL7, VE-statin, EGF-like protein 7, Multiple epidermal growth factor-like domains protein 7, Vascular endothelial statin
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q9UHF1
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names RG7414,RO5490248,CAS:1312797-14-0
Background Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HV171016_1.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Parsatuzumab.